| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.51 | 0.07 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.2 | 0.0002 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.19 | 0.0005 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.19 | 0.2 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.18 | 0.3 |